News
Yale Researcher Awarded $40 Million to Lead New VA Study to Evaluate Esketamine for Treatment Resistant Depression
Somaia Mohamed, MD, PhD, associate professor of psychiatry, is lead co-investigator of a Department of Veterans Affairs (VA) study that has been awarded $40 million to evaluate the effectiveness of a novel antidepressant medicine, esketamine, for veterans and others with treatment resistant depression (TRD).